These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 28209375

  • 1. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J, Rouyer MV, Lautsch D, Ashton V, Ambegaonkar BM, Brudi P, Gitt AK, Dyslipidemia International Study (DYSIS) II France Study Group.
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [Abstract] [Full Text] [Related]

  • 2. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.
    Ferrieres J, De Ferrari GM, Hermans MP, Elisaf M, Toth PP, Horack M, Brudi P, Lautsch D, Bash LD, Baxter CA, Ashton V, Ambegaonkar B, Gitt AK.
    Eur J Prev Cardiol; 2018 Dec; 25(18):1966-1976. PubMed ID: 30335504
    [Abstract] [Full Text] [Related]

  • 3. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Gitt AK, Lautsch D, Ferrières J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W, Chiang FT, Poh KK, Brudi P, Ambegaonkar B.
    Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
    [Abstract] [Full Text] [Related]

  • 4. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.
    Kristensen MS, Green A, Nybo M, Hede SM, Mikkelsen KH, Gislason G, Larsen ML, Ersbøll AK.
    BMC Cardiovasc Disord; 2020 Jul 13; 20(1):336. PubMed ID: 32660429
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
    Yan BP, Chiang FT, Ambegaonkar B, Brudi P, Horack M, Lautsch D, Vyas A, Gitt AK.
    Int J Cardiol; 2018 Aug 15; 265():1-5. PubMed ID: 29885676
    [Abstract] [Full Text] [Related]

  • 6. Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.
    Poh KK, Chin CT, Tong KL, Tan JKB, Lim JS, Yu W, Horack M, Vyas A, Lautsch D, Ambegaonkar B, Brudi P, Gitt AK.
    Singapore Med J; 2019 Sep 15; 60(9):454-462. PubMed ID: 30773600
    [Abstract] [Full Text] [Related]

  • 7. Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome.
    Ferrières J, Lautsch D, Bramlage P, Horack M, Baxter CA, Ambegaonkar B, Toth PP, Poh KK, De Ferrari GM, Gitt AK.
    Arch Cardiovasc Dis; 2020 Oct 15; 113(10):617-629. PubMed ID: 32873522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž, De Backer G, Fras Z, Kotseva K, Tokgözoglu L, Wood D, De Bacquer D, EUROASPIRE Investigators.
    Atherosclerosis; 2016 Mar 15; 246():243-50. PubMed ID: 26812002
    [Abstract] [Full Text] [Related]

  • 11. Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II.
    Buddhari W, Uerojanaungkul P, Sriratanasathavorn C, Sukonthasarn A, Ambegaonkar B, Brudi P, Horack M, Lautsch D, Vyas A, Gitt AK.
    Heart Lung Circ; 2020 Mar 15; 29(3):405-413. PubMed ID: 31006593
    [Abstract] [Full Text] [Related]

  • 12. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS).
    Danchin N, Almahmeed W, Al-Rasadi K, Azuri J, Berrah A, Cuneo CA, Karpov Y, Kaul U, Kayıkçıoğlu M, Mitchenko O, Ruiz AJ, Aguilar Salinas CA, Santos RD, Mercier F, Blom D, ICLPS Investigators.
    Eur J Prev Cardiol; 2018 Jul 15; 25(10):1087-1094. PubMed ID: 29771156
    [Abstract] [Full Text] [Related]

  • 13. Lipid management in ACS: Should we go lower faster?
    Gencer B, Mach F.
    Atherosclerosis; 2018 Aug 15; 275():368-375. PubMed ID: 30015301
    [Abstract] [Full Text] [Related]

  • 14. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.
    Hajahmadi Pourrafsanjani M, Khayati Shal E, Khezrpour S.
    High Blood Press Cardiovasc Prev; 2019 Feb 15; 26(1):37-43. PubMed ID: 30684247
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.